Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Feb-24 4:43 PM View:  | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 26-Feb-24 | Purchase | 930,851 | $7.52 | $7,000,000.00 | 12% 7.66M to 8.59M | |
| 26-Feb-24 8:07 PM View: | Dugel Pravin Executive Chairman Director | Ocular Therapeutix, Inc (OCUL) | 22-Feb-24 | Grant | 854,979 | -- | -- | 100% 0 to 854.98K | |
| 26-Feb-24 8:06 PM View: | Nayak Sanjay Chief Strategy Officer | Ocular Therapeutix, Inc (OCUL) | 22-Feb-24 | Grant | 80,300 | -- | -- | 80% 100.0K to 180.3K | |
| 06-Feb-24 6:32 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 05-Feb-24 | Sale | 6,346 | $4.86 | $30,841.60 | 4% 146.71K to 153.05K | |
| 06-Feb-24 6:26 PM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 05-Feb-24 | Sale | 19,642 | $4.86 | $95,460.10 | 3% 575.56K to 595.2K | |
| 06-Feb-24 6:38 PM View: | White Christopher G Chief Business Officer | Ocular Therapeutix, Inc (OCUL) | 05-Feb-24 | Sale | 5,910 | $4.86 | $28,722.60 | 5% 117.78K to 123.69K | |
| 06-Feb-24 6:35 PM View: | Strassburger Philip C. General Counsel | Ocular Therapeutix, Inc (OCUL) | 05-Feb-24 | Sale | 6,029 | $4.86 | $29,300.90 | 4% 155.46K to 161.49K | |
| 06-Feb-24 6:29 PM View: | Notman Donald Chief Financial Officer | Ocular Therapeutix, Inc (OCUL) | 05-Feb-24 | Sale | 6,212 | $4.86 | $30,190.30 | 3% 189.14K to 195.36K | |
| 06-Feb-24 6:35 PM View: | Strassburger Philip C. General Counsel | Ocular Therapeutix, Inc (OCUL) | 03-Feb-24 | Grant | 58,304 | -- | -- | 53% 109.22K to 167.52K | |
| 06-Feb-24 6:29 PM View: | Notman Donald Chief Financial Officer | Ocular Therapeutix, Inc (OCUL) | 03-Feb-24 | Grant | 61,636 | -- | -- | 44% 139.93K to 201.57K | |
| 06-Feb-24 6:32 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 03-Feb-24 | Grant | 66,633 | -- | -- | 72% 92.77K to 159.4K | |
| 06-Feb-24 6:26 PM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 03-Feb-24 | Grant | 180,400 | -- | -- | 42% 434.44K to 614.84K | |
| 06-Feb-24 6:38 PM View: | White Christopher G Chief Business Officer | Ocular Therapeutix, Inc (OCUL) | 03-Feb-24 | Grant | 39,980 | -- | -- | 45% 89.62K to 129.6K | |
| 02-Feb-24 7:02 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 31-Jan-24 | Sale | 7,764 | $4.95 | $38,431.80 | (8%) 100.53K to 92.77K | |
| 02-Feb-24 7:00 PM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 31-Jan-24 | Sale | 18,338 | $4.95 | $90,773.10 | (4%) 452.78K to 434.44K | |
| 02-Feb-24 7:01 PM View: | White Christopher G Chief Business Officer | Ocular Therapeutix, Inc (OCUL) | 31-Jan-24 | Sale | 5,147 | $4.95 | $25,477.60 | (5%) 94.77K to 89.62K | |
| 02-Feb-24 7:01 PM View: | Strassburger Philip C. General Counsel | Ocular Therapeutix, Inc (OCUL) | 31-Jan-24 | Sale | 6,831 | $4.95 | $33,813.40 | (6%) 116.05K to 109.22K | |
| 02-Feb-24 7:03 PM View: | Notman Donald Chief Financial Officer | Ocular Therapeutix, Inc (OCUL) | 31-Jan-24 | Sale | 6,433 | $4.95 | $31,843.30 | (4%) 146.37K to 139.93K | |
| 18-Dec-23 4:52 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 14-Dec-23 | Private Purchase | 1,538,460 | $3.25 | $5,000,000.00 | 25% 6.12M to 7.66M | |
| 05-Sep-23 8:27 AM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 30-Aug-23 | Private Purchase | 6,500 | $3.81 | $24,765.00 | 1% 446.28K to 452.78K | |
| 12-Jul-23 5:18 PM View: | Graves Adrienne L Director | Ocular Therapeutix, Inc (OCUL) | 10-Jul-23 | Grant | 24,000 | -- | -- | 100% 0 to 24.0K | |
| 11-Jul-23 8:00 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 07-Jul-23 | Sale | 832 | $4.93 | $4,101.76 | (< 1%) 101.36K to 100.53K | |
| 08-Feb-23 7:38 PM View: | White Christopher G Chief Business Officer | Ocular Therapeutix, Inc (OCUL) | 06-Feb-23 | Sale (Planned) | 5,829 | $4.24 | $24,715.00 | (6%) 100.59K to 94.77K | |
| 08-Feb-23 7:31 PM View: | Strassburger Philip C. General Counsel | Ocular Therapeutix, Inc (OCUL) | 06-Feb-23 | Sale (Planned) | 6,181 | $4.24 | $26,207.40 | (5%) 115.25K to 109.07K | |
| 08-Feb-23 7:32 PM View: | Notman Donald Chief Financial Officer | Ocular Therapeutix, Inc (OCUL) | 06-Feb-23 | Sale (Planned) | 6,476 | $4.24 | $27,458.20 | (4%) 145.86K to 139.39K | |
| 08-Feb-23 7:33 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 06-Feb-23 | Sale (Planned) | 6,416 | $4.24 | $27,203.80 | (6%) 107.78K to 101.36K | |
| 08-Feb-23 7:29 PM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 06-Feb-23 | Sale (Planned) | 19,669 | $4.24 | $83,396.60 | (4%) 465.95K to 446.28K | |
| 01-Feb-23 7:35 PM View: | Strassburger Philip C. General Counsel | Ocular Therapeutix, Inc (OCUL) | 30-Jan-23 | Grant | 55,556 | -- | -- | 93% 59.7K to 115.25K | |
| 01-Feb-23 7:33 PM View: | Notman Donald Chief Financial Officer | Ocular Therapeutix, Inc (OCUL) | 30-Jan-23 | Grant | 55,556 | -- | -- | 62% 90.31K to 145.86K | |
| 01-Feb-23 7:34 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 30-Jan-23 | Grant | 55,556 | -- | -- | 106% 52.22K to 107.78K | |
| 01-Feb-23 7:32 PM View: | Mattessich Antony C. President and CEO Director | Ocular Therapeutix, Inc (OCUL) | 30-Jan-23 | Grant | 176,300 | -- | -- | 61% 289.65K to 465.95K | |
| 01-Feb-23 7:36 PM View: | White Christopher G Chief Business Officer | Ocular Therapeutix, Inc (OCUL) | 30-Jan-23 | Grant | 44,444 | -- | -- | 79% 56.15K to 100.59K | |
| 09-Nov-22 4:48 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 07-Nov-22 | Private Purchase | 7,328 | $3.50 | $25,648.00 | < 1% 6.11M to 6.12M | |
| 12-Oct-22 4:34 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 11-Oct-22 | Purchase | 10,000 | $3.90 | $38,993.00 | < 1% 6.1M to 6.11M | |
| 12-Oct-22 4:34 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 10-Oct-22 | Private Purchase | 10,000 | $4.00 | $39,982.00 | < 1% 6.09M to 6.1M | |
| 29-Sep-22 7:51 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 29-Sep-22 | Purchase | 18,800 | $4.04 | $75,987.70 | < 1% 6.08M to 6.09M | |
| 29-Sep-22 7:51 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 28-Sep-22 | Purchase | 1,200 | $4.10 | $4,920.00 | < 1% 6.07M to 6.08M | |
| 29-Sep-22 7:51 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 27-Sep-22 | Private Purchase | 130,000 | $4.68 | $608,322.00 | 2% 5.94M to 6.07M | |
| 15-Jul-22 8:01 PM View: | Ozden Rabia Gurses Chief Medical Officer | Ocular Therapeutix, Inc (OCUL) | 01-Jul-22 | Grant | 6,667 | -- | -- | 15% 45.56K to 52.22K | |
| 21-Jun-22 8:05 PM View: | Heier Jeffrey S. Director | Ocular Therapeutix, Inc (OCUL) | 16-Jun-22 | Grant | 8,933 | -- | -- | 23% 39.0K to 47.93K | |
| 21-Jun-22 8:08 PM View: | Warden Charles M Director | Ocular Therapeutix, Inc (OCUL) | 16-Jun-22 | Grant | 8,933 | -- | -- | 23% 39.53K to 48.46K | |
| 21-Jun-22 8:10 PM View: | Raines Merilee Director | Ocular Therapeutix, Inc (OCUL) | 16-Jun-22 | Grant | 8,933 | -- | -- | 100% 0 to 8.93K | |
| 21-Jun-22 8:09 PM View: | Williams Leslie J. Director | Ocular Therapeutix, Inc (OCUL) | 16-Jun-22 | Grant | 8,933 | -- | -- | 199% 4.5K to 13.43K | |
| 21-Jun-22 8:06 PM View: | Hong Seung Suh Director | Ocular Therapeutix, Inc (OCUL) | 16-Jun-22 | Grant | 8,933 | -- | -- | 100% 0 to 8.93K | |
| 21-Jun-22 8:07 PM View: | Lindstrom Richard L Md Director | Ocular Therapeutix, Inc (OCUL) | 16-Jun-22 | Grant | 8,933 | -- | -- | 9% 99.47K to 108.4K | |
| 16-May-22 4:13 PM View: | Lindstrom Richard L Md Director | Ocular Therapeutix, Inc (OCUL) | 12-May-22 | Option Exercise | 9,469 | $1.22 | $11,552.20 | 11% 90.0K to 99.47K | |
| 16-May-22 10:00 PM View: | Heier Jeffrey S. Director | Ocular Therapeutix, Inc (OCUL) | 12-May-22 | Private Purchase | 15,000 | $3.05 | $45,750.00 | 62% 24.0K to 39.0K | |
| 23-Feb-22 5:08 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 23-Feb-22 | Purchase | 10,000 | $4.80 | $47,986.00 | < 1% 5.93M to 5.94M | |
| 23-Feb-22 5:08 PM View: | Summer Road LLC 10% Owner | Ocular Therapeutix, Inc (OCUL) | 18-Feb-22 | Private Purchase | 40,000 | $5.00 | $199,940.00 | < 1% 5.89M to 5.93M | |
| 07-Feb-22 7:31 PM View: | White Christopher G Chief Business Officer | Ocular Therapeutix, Inc (OCUL) | 03-Feb-22 | Grant | 50,000 | -- | -- | 2351% 2.13K to 52.13K |
